Tag: biosimilar vs generic

Lot-to-Lot Variability in Biologics and Biosimilars: What It Really Means for Patients 27 February 2026

Lot-to-Lot Variability in Biologics and Biosimilars: What It Really Means for Patients

Lot-to-lot variability is a natural part of biologic and biosimilar manufacturing. Unlike generics, biosimilars aren't identical copies - they're highly similar, with controlled variations that don't affect safety or effectiveness. This is how modern biologics work.

Manufacturing Challenges for Biosimilars: Complex Production Explained 3 January 2026

Manufacturing Challenges for Biosimilars: Complex Production Explained

Biosimilars are complex biologic drugs that can't be copied like generic pills. Their production requires precise control over living cells, glycosylation, and scaling - making them far harder and costlier to manufacture than traditional generics.